SNDL (SNDL) Competitors

SNDL logo
$1.86 0.00 (0.00%)
Closing price 02/14/2025 04:00 PM Eastern
Extended Trading
$1.86 +0.00 (+0.27%)
As of 02/14/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNDL vs. IDYA, AGIO, SDGR, APGE, NAMS, BLTE, TVTX, IRON, IOVA, and WVE

Should you be buying SNDL stock or one of its competitors? The main competitors of SNDL include IDEAYA Biosciences (IDYA), Agios Pharmaceuticals (AGIO), Schrödinger (SDGR), Apogee Therapeutics (APGE), NewAmsterdam Pharma (NAMS), Belite Bio (BLTE), Travere Therapeutics (TVTX), Disc Medicine (IRON), Iovance Biotherapeutics (IOVA), and Wave Life Sciences (WVE). These companies are all part of the "pharmaceutical products" industry.

SNDL vs.

SNDL (NASDAQ:SNDL) and IDEAYA Biosciences (NASDAQ:IDYA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

SNDL currently has a consensus price target of $3.25, indicating a potential upside of 74.73%. IDEAYA Biosciences has a consensus price target of $53.58, indicating a potential upside of 155.16%. Given IDEAYA Biosciences' higher possible upside, analysts plainly believe IDEAYA Biosciences is more favorable than SNDL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
IDEAYA Biosciences
0 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.94

SNDL has a beta of 3.11, suggesting that its stock price is 211% more volatile than the S&P 500. Comparatively, IDEAYA Biosciences has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500.

In the previous week, IDEAYA Biosciences had 19 more articles in the media than SNDL. MarketBeat recorded 19 mentions for IDEAYA Biosciences and 0 mentions for SNDL. IDEAYA Biosciences' average media sentiment score of 0.30 beat SNDL's score of -0.10 indicating that IDEAYA Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
SNDL Neutral
IDEAYA Biosciences Neutral

IDEAYA Biosciences has a net margin of 0.00% compared to SNDL's net margin of -12.11%. SNDL's return on equity of -8.27% beat IDEAYA Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SNDL-12.11% -8.27% -6.96%
IDEAYA Biosciences N/A -19.42%-18.63%

98.3% of IDEAYA Biosciences shares are held by institutional investors. 3.5% of IDEAYA Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

IDEAYA Biosciences received 1 more outperform votes than SNDL when rated by MarketBeat users. However, 72.31% of users gave SNDL an outperform vote while only 71.72% of users gave IDEAYA Biosciences an outperform vote.

CompanyUnderperformOutperform
SNDLOutperform Votes
141
72.31%
Underperform Votes
54
27.69%
IDEAYA BiosciencesOutperform Votes
142
71.72%
Underperform Votes
56
28.28%

IDEAYA Biosciences has lower revenue, but higher earnings than SNDL. IDEAYA Biosciences is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SNDL$673.33M0.73-$127.91M-$0.31-6.00
IDEAYA Biosciences$23.39M77.60-$112.96M-$2.33-9.01

Summary

IDEAYA Biosciences beats SNDL on 11 of the 19 factors compared between the two stocks.

Get SNDL News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDL vs. The Competition

MetricSNDLMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$488.77M$1.20B$5.76B$9.22B
Dividend YieldN/AN/A5.27%4.00%
P/E Ratio-6.0039.6026.2019.44
Price / Sales0.735.72456.5777.34
Price / CashN/A10.8846.0638.90
Price / Book0.541.917.355.05
Net Income-$127.91M-$53.22M$3.19B$222.81M
7 Day Performance0.54%2.06%1.69%1.29%
1 Month Performance4.49%3.83%4.13%1.52%
1 Year Performance24.83%-7.80%22.24%16.53%

SNDL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNDL
SNDL
3.6134 of 5 stars
$1.86
flat
$3.25
+74.7%
+24.8%$488.77M$673.33M-6.002,516
IDYA
IDEAYA Biosciences
3.6893 of 5 stars
$22.43
-2.5%
$53.67
+139.3%
-55.4%$1.94B$23.39M-9.6380Earnings Report
Analyst Forecast
Analyst Revision
AGIO
Agios Pharmaceuticals
4.2447 of 5 stars
$33.92
+1.4%
$56.33
+66.1%
+25.3%$1.92B$26.82M2.97390Earnings Report
Analyst Downgrade
Short Interest ↓
SDGR
Schrödinger
2.1591 of 5 stars
$25.24
-1.7%
$32.11
+27.2%
-23.5%$1.84B$216.67M-10.78790Positive News
APGE
Apogee Therapeutics
2.5885 of 5 stars
$39.37
-0.9%
$89.71
+127.9%
+1.7%$1.78BN/A-16.3191
NAMS
NewAmsterdam Pharma
3.4162 of 5 stars
$19.24
-4.7%
$41.60
+116.3%
-3.9%$1.78B$14.09M0.004Positive News
BLTE
Belite Bio
3.5122 of 5 stars
$53.79
-6.5%
$96.33
+79.1%
+17.6%$1.66BN/A-48.5410Short Interest ↓
TVTX
Travere Therapeutics
2.4491 of 5 stars
$21.08
-3.1%
$24.00
+13.9%
+179.4%$1.64B$145.24M-4.63460
IRON
Disc Medicine
2.0913 of 5 stars
$54.40
-0.8%
$88.90
+63.4%
-17.9%$1.62BN/A-13.7030Short Interest ↑
IOVA
Iovance Biotherapeutics
4.0949 of 5 stars
$5.32
-6.6%
$22.69
+326.9%
-39.1%$1.62B$90.86M-3.57500
WVE
Wave Life Sciences
4.2973 of 5 stars
$10.65
-4.7%
$22.22
+108.7%
+176.5%$1.62B$53.61M-9.58240

Related Companies and Tools


This page (NASDAQ:SNDL) was last updated on 2/17/2025 by MarketBeat.com Staff
From Our Partners